Company news

Vicore Pharma Holding AB news in 2026

Vicore Pharma Holding AB's news releases, calls and decks from 2026, newest first.

View company

Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum

September 17, 2026

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

July 6, 2026

Vicore Pharma to Commence Trading in the United States on The Nasdaq Stock Market

July 1, 2026

Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

May 22, 2026

Vicore Pharma Elects Peter Guenter to its Board of Directors

May 7, 2026

Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

May 6, 2026

Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

April 29, 2026

Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

April 22, 2026

Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)

April 1, 2026

Vicore Publishes the Annual Report for 2025

March 26, 2026

Vicore Pharma to Present at Upcoming Investor Conferences

March 9, 2026

Vicore Pharma Elevates Leadership Team Ahead of Key Clinical and Corporate Milestones

March 5, 2026

Vicore Pharma Holding AB - Year-end report 2025

March 2, 2026

Year-End Report 2025

February 27, 2026

Vicore Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

February 18, 2026

Vicore Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 7, 2026

Decks in 2026